Loading…
Loading…
MVMDF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MVMDF and 80,000+ other tickers.
See exactly how MVMDF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MVMDF and 80,000+ other tickers.
Mountain Valley MD Holdings Inc., operating through its subsidiary Mountain Valley MD Inc., is a company focused on the health and wellness industry. The firm's business model involves deploying and licensing its proprietary technologies to external partners within the pharmaceutical, vaccine, and nutraceutical sectors. Its portfolio includes Quicksome, an advanced oral drug formulation and delivery system; Quicksol, a technology designed to improve solubility; and a dose-sparing adjuvant. Currently, the company is also progressing with the development of IM032, a treatment being tested in…
TORONTO--(BUSINESS WIRE)--The More Life Company Corp. (the “Company”), formerly Mountain Valley MD Holdings Inc. (CSE: MVMD) (OTC: MVMDF), is pleased to announce that it has completed a corporate name change from Mountain Valley MD Holdings Inc. to The More Life Company Corp. (the “Name Change”) as part of the Company's rebranding strategy. Subject to final processing by the Canadian Securities Exchange (the “CSE”), the Company expects its common shares to commence trading on the CSE under the.
Mountain Valley MD Holdings Inc. (the âCompanyâ or âMVMDâ) (CSE: MVMD) (OTC: MVMDF) is pleased to announce the appointment of five additional advisors t
TORONTO--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTC: MVMDF) is pleased to announce the appointment of five additional advisors to the Company, as well as the grant of stock options to certain advisors and consultants of the Company. APPOINTMENT OF ADVISORS The Company has appointed the five individuals listed below as advisors to provide strategic advisory services to the Company. The advisors may receive compensation, including equity-based com.
TORONTO--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTC: MVMDF) is pleased to report on the advancement of its patented Quicksome™ sublingual delivery platform as part of the Company's strategy to position Quicksome™ as a differentiated delivery solution within the evolving compounded peptide marketplace across North and South America. Over the past six months, the Company has expanded its internal formulation capabilities following investments in l.
TORONTO--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The updated release reads: MOUNTAIN VALLEY MD ANNOUNCES APPOINTMENT OF ADVISORS AND STOCK OPTION GRANTS Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTC: MVMDF) announces that it is issuing this amended and updated news release to correct inadvertent errors in the biographical information of certain advisors previously announced in its news release issu.